July 27, 2017 / 11:28 AM / 2 years ago

BRIEF-Arbutus announces conclusion of LNP license agreement with Alexion

July 27 (Reuters) - Arbutus Biopharma Corp

* Arbutus announces conclusion of LNP license agreement with Alexion

* Has received notice of termination from Alexion Pharmaceuticals Holding

* Termination from Alexion Pharmaceuticals Holding for companies’ LNP license agreement, which signed and announced in March 2017

* Termination of agreement was driven by a strategic review of Alexion’s business and research and development portfolio Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below